WallStreetZenWallStreetZen

NASDAQ: CNTX
Context Therapeutics Inc Stock

$2.02+0.00 (+0%)
Updated Jul 12, 2024
CNTX Price
$2.02
Fair Value Price
$0.91
Market Cap
$151.50M
52 Week Low
$0.77
52 Week High
$2.24
P/E
-1.52x
P/B
17.94x
P/S
N/A
PEG
N/A
Dividend Yield
N/A
Revenue
$0.00
Earnings
-$21.32M
Gross Margin
N/A
Operating Margin
N/A
Profit Margin
N/A
Debt to Equity
0.31
Operating Cash Flow
-$20M
Beta
0.93
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A

CNTX Overview

Context Therapeutics Inc. is a clinical-stage biopharmaceutical company developing cancer treatments for women. Candidates include ONA-XR (onapristone extended release) to treat female hormone-dependent cancers, and CLDN6xCD3 bsAb, intended to redirect T-cell-mediated lysis toward malignant cells expressing CLDN6 (Claudin 6). The company has a collaboration and licensing agreement with Integral Molecular, Inc. for the development of an anti-claudin 6 bispecific monoclonal antibody for gynaecologic cancer therapy. Context Therapeutics was incorporated in 2015 and is headquartered in Philadelphia, PA.

Zen Score

Industry Average (23)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how CNTX scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

CNTX ($2.02) is overvalued by 123.2% relative to our estimate of its Fair Value price of $0.91 based on Discounted Cash Flow (DCF) modelling
Below Fair Value Valuation
CNTX ($2.02) is not significantly undervalued (123.2%) relative to our estimate of its Fair Value price of $0.91 based on Discounted Cash Flow (DCF) modelling, when including a healthy margin of safety
Significantly Below Fair Value Valuation
CNTX is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
There are 30 more CNTX due diligence checks available for Premium users.

Be the first to know about important CNTX news, forecast changes, insider trades & much more!

CNTX News

Valuation

CNTX fair value

Fair Value of CNTX stock based on Discounted Cash Flow (DCF)
Price
$2.02
Fair Value
$0.91
Overvalued by
123.20%
CNTX ($2.02) is overvalued by... subscribe to Premium to read more.
Below Fair Value Valuation
CNTX ($2.02) is not significantly... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
CNTX is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation

CNTX price to earnings (PE)

For valuing profitable companies with steady earnings
Company
-1.52x
Industry
-12.81x
Market
32.2x

CNTX price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
17.94x
Industry
6.45x
CNTX is poor value based... subscribe to Premium to read more.
P/B vs Industry Valuation

CNTX's financial health

Profit margin

Revenue
$0.0
Net Income
-$3.7M
Profit Margin
0%
CNTX's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials

Assets to liabilities

Assets
$11.1M
Liabilities
$2.6M
Debt to equity
0.31
CNTX's short-term assets ($11.04M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
CNTX's short-term assets ($11.04M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
CNTX's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
-$4.4M
Investing
$0.0
Financing
$0.0
CNTX's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials

CNTX vs Biotech Stocks

TickerMarket Cap1d %P/EP/B
CNTX$151.50M0.00%-1.52x17.94x
QSI$151.74M-0.93%-1.65x0.60x
CLLS$150.08M+4.50%-1.88x1.66x
PDSB$150.02M+5.41%-2.99x4.03x
CMPX$148.60M+3.85%-3.09x0.95x

Context Therapeutics Stock FAQ

What is Context Therapeutics's quote symbol?

(NASDAQ: CNTX) Context Therapeutics trades on the NASDAQ under the ticker symbol CNTX. Context Therapeutics stock quotes can also be displayed as NASDAQ: CNTX.

If you're new to stock investing, here's how to buy Context Therapeutics stock.

What is the 52 week high and low for Context Therapeutics (NASDAQ: CNTX)?

(NASDAQ: CNTX) Context Therapeutics's 52-week high was $2.24, and its 52-week low was $0.77. It is currently -9.82% from its 52-week high and 162.34% from its 52-week low.

How much is Context Therapeutics stock worth today?

(NASDAQ: CNTX) Context Therapeutics currently has 74,998,312 outstanding shares. With Context Therapeutics stock trading at $2.02 per share, the total value of Context Therapeutics stock (market capitalization) is $151.50M.

Context Therapeutics stock was originally listed at a price of $5.10 in Oct 20, 2021. If you had invested in Context Therapeutics stock at $5.10, your return over the last 2 years would have been -60.39%, for an annualized return of -37.07% (not including any dividends or dividend reinvestments).

How much is Context Therapeutics's stock price per share?

(NASDAQ: CNTX) Context Therapeutics stock price per share is $2.02 today (as of Jul 12, 2024).

What is Context Therapeutics's Market Cap?

(NASDAQ: CNTX) Context Therapeutics's market cap is $151.50M, as of Jul 14, 2024.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Context Therapeutics's market cap is calculated by multiplying CNTX's current stock price of $2.02 by CNTX's total outstanding shares of 74,998,312.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.